Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.390
+0.100 (4.37%)
Nov 22, 2024, 4:00 PM EST - Market closed
Protara Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 17.3 | 18.62 | 20.74 | 26.4 | 22.46 | 3.95 | |
| Research & Development | 28.59 | 24.99 | 16.81 | 21.09 | 11.98 | 3.88 | |
| Operating Expenses | 45.88 | 43.61 | 37.55 | 47.49 | 34.44 | 7.83 | |
| Operating Income | -45.88 | -43.61 | -37.55 | -47.49 | -34.44 | -7.83 | |
| Interest Expense | - | - | - | - | -0.03 | - | |
| Interest & Investment Income | 3.84 | 3.19 | 1.11 | 0.24 | 0.5 | - | |
| EBT Excluding Unusual Items | -42.05 | -40.42 | -36.44 | -47.25 | -33.98 | -7.83 | |
| Impairment of Goodwill | - | - | -29.52 | - | - | - | |
| Pretax Income | -42.05 | -40.42 | -65.95 | -47.25 | -33.98 | -7.83 | |
| Net Income | -42.05 | -40.42 | -65.95 | -47.25 | -33.98 | -7.83 | |
| Net Income to Common | -42.05 | -40.42 | -65.95 | -47.25 | -33.98 | -7.83 | |
| Shares Outstanding (Basic) | 17 | 11 | 11 | 11 | 7 | 3 | |
| Shares Outstanding (Diluted) | 17 | 11 | 11 | 11 | 7 | 3 | |
| Shares Change (YoY) | 46.80% | 0.64% | 0.24% | 55.28% | 180.66% | -76.99% | |
| EPS (Basic) | -2.53 | -3.57 | -5.86 | -4.21 | -4.70 | -3.04 | |
| EPS (Diluted) | -2.53 | -3.57 | -5.86 | -4.21 | -4.70 | -3.04 | |
| Free Cash Flow | - | -37.6 | -26.58 | -35.1 | -24.29 | -5.49 | |
| Free Cash Flow Per Share | - | -3.32 | -2.36 | -3.12 | -3.36 | -2.13 | |
| EBITDA | -45.53 | -43.27 | -37.3 | -47.37 | -34.34 | -7.81 | |
| D&A For EBITDA | 0.36 | 0.34 | 0.25 | 0.12 | 0.1 | 0.02 | |
| EBIT | -45.88 | -43.61 | -37.55 | -47.49 | -34.44 | -7.83 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.